Enjoy complimentary customisation on priority with our Enterprise License!
Ankylosing spondylitis can be defined as a type of arthritis that affects the joints of the spine and causes inflammation of spinal joints. Patients suffering from this condition experience severe discomfort and chronic pain. This condition also affects other areas of the body such as heels, small joints of hands and feet, ribs, shoulders, and hips. In addition, the progression of this disease can affect the mobility of the patient by causing abnormal joining of bones or fused vertebrae and overgrowth of bones. Technavio’s market research analysts have predicted that with the introduction of medications, therapy, and surgery as some of the most promising investigational approaches to treat ankylosing spondylitis, the ankylosing spondylitis market size will increase in the forthcoming years.
According to this pipeline analysis report, most of the drug development molecules in the pipeline are being produced under the phase II drug development stage. The pipeline landscape in the pipeline analysis report mentions the percentage of drug development molecules that are under pre-clinical, phase III, and discovery stage.
Based on the ankylosing spondylitis industry analysis, this pipeline report provides a detailed analysis of the companies that are involved in the development of drug development molecules for the treatment of for ankylosing spondylitis. In addition to providing information on the various stages of molecules developed by companies for different indications, this pipeline analysis report also provides information about the drug development molecules discontinued by companies.
Some of the companies covered in this pipeline analysis report are –
The subcutaneous route of administration (ROA) involves the administration of drug substances directly into the tissue layer between the skin and the muscle with a short needle. It has been observed that the majority of total therapeutics are being developed for subcutaneous administration.
According to this pipeline analysis report, the majority of molecules that are currently in the drug development pipeline for ankylosing spondylitis are being developed as a biological molecule. Biological molecules include macro-molecules or polyanions such as proteins, starches, lipids, and nucleic acid. They also include small molecules such as essential metabolites, auxiliary metabolites, and regular items.
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MAJOR REGULATORY AUTHORITIES
PART 06: PIPELINE LANDSCAPE
PART 07: COMPARATIVE ANALYSIS
PART 08: INDICATION ANALYSIS
PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)
PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)
PART 11: THERAPEUTIC ASSESSMENT BY TARGET
PART 12: KEY COMPANIES
PART 13: APPENDIX
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.